The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated•Originally published 3 March 2026•Updated 3 March 2026•

1 min read

SpaceX Accelerates IPO to 2024 with Expectations of 'Tesla on Steroids' Volatility

Portrait of Elon Musk over a golden world map showing Tesla cars, factories, and a red downward trend line.

Key Facts

1Analysts suggest SpaceX could go public in 2026.

3 months ago

Version History

Version 13 months ago

What changed: The projected IPO timeline was moved from 2026 to 2024, and analysts intensified volatility warnings, comparing it to 'Tesla on steroids'.

SpaceX is reportedly planning to go public as early as this year (2024), significantly accelerating its IPO timeline from the previously projected 2026. This strategic shift has intensified market focus, with analysts describing the potential trading behavior of SpaceX shares as 'Tesla on steroids' due to expected extreme price volatility. This anticipated turbulence is driven by the company's high-growth aerospace profile combined with the 'Elon Musk premium' that typically attracts aggressive speculative interest. The IPO is set to be a landmark event for the aerospace industry, likely triggering a massive reallocation of capital toward Musk-led ventures. While the valuation outlook remains robust, experts are cautioning investors about the heightened risks inherent in such a high-profile market debut. The accelerated timeline is expected to immediately reshape investor sentiment and strategies across the broader technology and space sectors.